Merck Stays Confident On M&A Despite Market Uncertainty: Analyst
1. Merck's M&A efforts continue despite complex market conditions. 2. Potential deals could exceed $15 billion, emphasizing growth strategy. 3. Q1 2025 adjusted earnings beat consensus, signaling strong performance. 4. Tariffs will increase costs by approximately $200 million, affecting margins. 5. Goldman Sachs maintains a buy rating, adjusting price target to $99.